Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

CCEL

Cryo-Cell International Inc

May 01 • 12:48PM ET

3.48

+0.06 1.75 %

Healthcare • Medical Care Facilities • USA • Nano • AMEX

Peers: CYRX VERU KRYS COOP KOD MRNS ARCT

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-0.33	Insider Own	47.82%	Shs Outstand	8.06M	Perf Week	-5.18%
Market Cap	28.03M	Forward P/E	174.00	EPS next Y	0.02	Insider Trans	0.00%	Shs Float	4.20M	Perf Month	-3.60%
Enterprise Value	35.84M	PEG	-	EPS next Q	0.00	Inst Own	12.46%	Short Float	0.19%	Perf Quarter	4.82%
Income	-2.67M	P/S	0.90	EPS this Y	136.67%	Inst Trans	-25.45%	Short Ratio	0.57	Perf Half Y	-20.93%
Sales	31.28M	P/B	-	EPS next Y	-81.82%	ROA	-4.26%	Short Interest	0.01M	Perf YTD	1.17%
Book/sh	-2.28	P/C	9.67	EPS next 5Y	-	ROE	-	52W High	6.35 -45.20%	Perf Year	-33.08%
Cash/sh	0.36	P/FCF	5.67	EPS past 3/5Y	- -	ROIC	-	52W Low	2.72 27.94%	Perf 3Y	-45.11%
Dividend Est.	-	EV/EBITDA	22.98	Sales past 3/5Y	1.33% 0.27%	Gross Margin	75.09%	Volatility	13.50% 8.69%	Perf 5Y	-54.44%
Dividend TTM	0.15 (4.31%)	EV/Sales	1.15	EPS Y/Y TTM	-2181.76%	Oper. Margin	0.61%	ATR (14)	0.29	Perf 10Y	21.97%
Dividend Ex-Date	May 21, 2025	Quick Ratio	0.60	Sales Y/Y TTM	-2.56%	Profit Margin	-8.52%	RSI (14)	48.69	Recom	1.00
Dividend Gr. 3/5Y	-23.69% -	Current Ratio	0.62	EPS Q/Q	-83.19%	SMA20	-3.40%	Beta	0.48	Target Price	8.50
Payout	-	Debt/Eq	-	Sales Q/Q	-3.59%	SMA50	2.66%	Rel Volume	0.89	Prev Close	3.42
Employees	76	LT Debt/Eq	-	Earnings	Apr 14 AMC	SMA200	-12.71%	Avg Volume	13.94K	Price	3.48
IPO	Apr 04, 1994	Option/Short	No / Yes	EPS/Sales Surpr.	150.00% -0.26%	Trades		Volume	6,548	Change	1.75%

Apr-28-26 04:00PM	Cryo-Cell International Receives FACT Re-accreditation, Setting the Longest Independently Validated Quality Track Record Among U.S. Private Cord Blood Banks (Business Wire) -14.95%
Mar-12-26 05:00PM	Cryo-Cell Receives NYSE American Continued Listing Notice (Business Wire) -6.11%
Feb-27-26 05:00PM	Cryo-Cell Reports Financial Results for Fiscal Year Ended November 30, 2025 (Business Wire)
Aug-14-25 08:30AM	Cryo-Cell International, Inc. Provides Dividend Update (Business Wire) -9.67%
Jul-15-25 05:00PM	Cord Blood Banking Leader Cryo-Cell Reports Fiscal Second Quarter 2025 Financial Results (Business Wire)
05:00PM	Loading…
May-08-25 05:00PM	Cord Blood Banking Leader Cryo-Cell Announces Cash Dividend (Business Wire)
Apr-16-25 11:59AM	Big banks report Q1 beats, China stops taking Boeing deliveries: Morning Buzz (TipRanks) +9.48%
Apr-15-25 08:30AM	Cord Blood Banking Leader Cryo-Cell Reports Fiscal First Quarter 2025 Financial Results (Business Wire)
Jan-29-25 04:15PM	Cord Blood Banking Leader Cryo-Cell Announces Regular Quarterly Cash Dividend and Pause of Strategic Initiatives (Business Wire)
Oct-30-24 08:45AM	Cord Blood Banking Leader Cryo-Cell Declares Initiation of Regular Quarterly Cash Dividend (Business Wire) +25.60%
Oct-15-24 05:20PM	Cord Blood Banking Leader Cryo-Cell Reports Fiscal Third Quarter 2024 Financial Results (Business Wire) +6.98%
Jul-15-24 04:30PM	Cord Blood Banking Leader Cryo-Cell Reports Fiscal Second Quarter 2024 Financial Results (Business Wire) -6.07%
Apr-15-24 05:00PM	Cord Blood Banking Leader Cryo-Cell Reports Fiscal First Quarter 2024 Financial Results (Business Wire) -5.37%
Mar-25-24 09:00AM	Cryo-Cell Announces Plans to Explore Strategic Alternatives and Spin-off Celle Corp. to Maximize Shareholder Value (Business Wire) +7.64%
Feb-28-24 05:00PM	Cryo-Cell Reports Financial Results for Fiscal Year Ended November 30, 2023 (Business Wire)
04:15PM	Loading…
Jan-22-24 04:15PM	Maxim Group LLC to Host the 2024 Healthcare IT Virtual Conference on Wednesday, January 24th & Thursday, January 25th at 9:00 A.M. ET (GlobeNewswire)
Oct-12-23 04:45PM	Cord Blood Banking Leader Cryo-Cell Reports Fiscal Third Quarter 2023 Financial Results (Business Wire)
Jul-14-23 04:15PM	Cord Blood Banking Leader Cryo-Cell Reports Fiscal Second Quarter 2023 Financial Results (Business Wire) -9.50%
Apr-21-23 04:15PM	Cord Blood Banking Leader Cryo-Cell Reports Fiscal First Quarter 2023 Financial Results (Business Wire) +14.74%
Feb-28-23 05:15PM	Cryo-Cell Reports Financial Results for Fiscal Year Ended November 30, 2022 (GlobeNewswire)
Jan-24-23 11:00AM	Maxim Group LLC to Host the Healthcare IT Virtual Conference on Wednesday, January 25th at 8:15 A.M. ET (GlobeNewswire)
Oct-14-22 04:15PM	Cord Blood Banking Leader Cryo-Cell Reports Fiscal Third Quarter 2022 Financial Results (GlobeNewswire)
Aug-22-22 06:00PM	Cord Blood Banking Leader Cryo-Cell Announces Special Cash Dividend (GlobeNewswire) +15.38%
Aug-17-22 05:00PM	Cord Blood Banking Leader Cryo-Cell Announces Transfer to the NYSE American Stock Exchange (GlobeNewswire) +10.36% -7.65%
Jul-11-22 04:30PM	Cord Blood Banking Leader Cryo-Cell Reports Fiscal Second Quarter 2022 Financial Results (GlobeNewswire)
Apr-13-22 04:30PM	Cord Blood Banking Leader Cryo-Cell Reports Fiscal First Quarter 2022 Financial Results (GlobeNewswire)
Mar-16-22 04:30PM	Cord Blood Banking Leader Cryo-Cell Announces Extravault Biorepository Service (GlobeNewswire)
Mar-09-22 04:15PM	Cryo-Cell Shares Its 2021 Annual Letter to Shareholders (GlobeNewswire)
Feb-22-22 04:30PM	Cryo-Cell Reports Financial Results for Fiscal Year Ended November 30, 2021 (GlobeNewswire) +7.00% -10.03%
Oct-27-21 04:15PM	Cord Blood Banking Leader Cryo-Cell Announces Its Intent to Advance Clinical Trials (GlobeNewswire)
04:36PM	Loading…
Oct-15-21 04:36PM	Cord Blood Banking Leader Cryo-Cell Reports Fiscal Third Quarter 2021 Financial Results (GlobeNewswire)
Sep-20-21 06:05PM	Cryo-Cell International Announces Changes To Its Board of Directors (GlobeNewswire) -5.45% +6.51%
Aug-30-21 09:00AM	Cryo-Cell International Announces Uplisting to The Nasdaq Capital Market (GlobeNewswire) +7.82%
Aug-20-21 09:04AM	Cryo-Cell International Completes Acquisition of Real Estate Property for Its Institute for Cellular Therapies (GlobeNewswire)
Aug-11-21 12:03PM	Cryo-Cell International to Present at the Q3 Virtual Investor Summit on August 18, 2021 (Newsfile)
09:00AM	Cryo-Cell International to Present at the Q3 Virtual Investor Summit (GlobeNewswire)
Jul-15-21 07:27PM	Cord Blood Banking Leader Cryo-Cell Reports Fiscal Second Quarter 2021 Financial Results (GlobeNewswire)
May-10-21 09:00AM	Cryo-Cell International Proudly Announces Two Ongoing COVID-19 Related Trials (GlobeNewswire)
Apr-14-21 06:14PM	Cord Blood Banking Leader Cryo-Cell Reports Fiscal First Quarter 2021 Financial Results (GlobeNewswire)
Feb-26-21 09:30AM	Cord Blood Banking Leader Cryo-Cell International Enters Into An Exclusive License Agreement with Duke University (GlobeNewswire) +11.11%
Feb-24-21 04:30PM	Cryo-Cell Reports Financial Results for Fiscal Year Ended November 30, 2020 (GlobeNewswire)
Oct-15-20 04:39PM	Cord Blood Banking Leader Cryo-Cell Reports Fiscal Third Quarter 2020 Financial Results (GlobeNewswire)

Cryo-Cell International, Inc. is a cord blood bank, which engages in providing stem cell cryopreservation services and advancing regenerative medicine. It operates through the following segments: Umbilical Cord Blood and Cord Tissue Stem Cell Service, PrepaCyte CB, and Public Cord Blood Banking. The Umbilical Cord Blood and Cord Tissue Stem Cell Service segment refers to cellular processing and cryogenic storage of umbilical cord blood and cord tissue stem cells for family use. The PrepaCyte CB segment focuses on the manufacture of PrepaCyte CB units, the processing technology used to process umbilical cord blood stem cells. The Public Cord Blood Banking segment relates to the cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. The company was founded in 1989 and is headquartered in Oldsmar, FL.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
PORTNOY DAVID	Chairman, Co-CEO	Sep 16 '25	Buy	4.46	6,449	28,763	818,369	Sep 18 04:53 PM
PORTNOY DAVID	Chairman, Co-CEO	Sep 17 '25	Buy	4.43	5,564	24,649	823,933	Sep 18 04:53 PM
PORTNOY DAVID	Chairman, Co-CEO	Sep 18 '25	Buy	4.46	3,411	15,213	827,344	Sep 18 04:53 PM
PORTNOY DAVID	Chairman, Co-CEO	Sep 18 '25	Buy	4.49	1,751	7,862	161,833	Sep 18 04:53 PM
PORTNOY DAVID	Chairman, Co-CEO	Sep 10 '25	Buy	4.44	25,139	111,692	268,878	Sep 10 05:22 PM
PORTNOY DAVID	Chairman, Co-CEO	Sep 10 '25	Buy	4.42	7,178	31,727	811,920	Sep 10 05:22 PM
PORTNOY DAVID	Chairman, Co-CEO	Sep 09 '25	Buy	4.49	5,312	23,849	257,843	Sep 10 05:22 PM
PORTNOY DAVID	Chairman, Co-CEO	Sep 08 '25	Buy	4.31	5,271	22,718	253,028	Sep 10 05:22 PM
PORTNOY DAVID	Chairman, Co-CEO	Aug 25 '25	Buy	4.61	14,000	64,560	241,539	Aug 27 05:23 PM
PORTNOY DAVID	Chairman, Co-CEO	Aug 27 '25	Buy	4.43	14,078	62,349	247,757	Aug 27 05:23 PM
PORTNOY DAVID	Chairman, Co-CEO	Aug 26 '25	Buy	4.44	11,101	49,288	156,322	Aug 27 05:23 PM
PORTNOY DAVID	Chairman, Co-CEO	Aug 18 '25	Buy	4.37	9,327	40,759	134,836	Aug 19 05:00 PM
PORTNOY DAVID	Chairman, Co-CEO	Aug 15 '25	Buy	4.45	9,089	40,451	237,039	Aug 19 05:00 PM
PORTNOY DAVID	Chairman, Co-CEO	Aug 19 '25	Buy	4.37	885	3,867	135,721	Aug 19 05:00 PM
PORTNOY DAVID	Chairman, Co-CEO	Aug 14 '25	Buy	4.17	5,826	24,305	122,838	Aug 18 05:34 PM
Berger Harold D.	Director	Jul 08 '25	Option Exercise	3.08	7,500	23,100	57,901	Jul 10 05:00 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

CCEL

Cryo-Cell International Inc

Upgrade your Finviz experience